BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25786692)

  • 1. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
    Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
    Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.
    Meylan F; Hawley ET; Barron L; Barlow JL; Penumetcha P; Pelletier M; Sciumè G; Richard AC; Hayes ET; Gomez-Rodriguez J; Chen X; Paul WE; Wynn TA; McKenzie AN; Siegel RM
    Mucosal Immunol; 2014 Jul; 7(4):958-68. PubMed ID: 24368564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 6. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for BATF3 in T
    Tsuda M; Hamade H; Thomas LS; Salumbides BC; Potdar AA; Wong MH; Nunnelee JS; Stamps JT; Neutzsky-Wulff AV; Barrett RJ; Wang Y; Tang J; Funari VA; Targan SR; Michelsen KS
    Mucosal Immunol; 2019 May; 12(3):644-655. PubMed ID: 30617301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
    Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW
    Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders.
    Steele H; Sachen K; McKnight AJ; Soloff R; Herro R
    Front Immunol; 2021; 12():692127. PubMed ID: 34305924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma.
    Niese ML; Pajulas AL; Rostron CR; Cheung CCL; Krishnan MS; Zhang J; Cannon AM; Kaplan MH
    Mucosal Immunol; 2024 Mar; ():. PubMed ID: 38493956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion.
    Wang D; Li H; Duan YY; Han F; Luo YX; Wu MY; Yang MY; Zhan RR; Song J; Zhang H; Zhang XL
    Life Sci; 2019 Aug; 231():116536. PubMed ID: 31176785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology.
    Meylan F; Siegel RM
    Semin Immunopathol; 2017 Jan; 39(1):21-28. PubMed ID: 27896636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
    Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
    Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
    Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
    Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TH9 cells are required for tissue mast cell accumulation during allergic inflammation.
    Sehra S; Yao W; Nguyen ET; Glosson-Byers NL; Akhtar N; Zhou B; Kaplan MH
    J Allergy Clin Immunol; 2015 Aug; 136(2):433-40.e1. PubMed ID: 25746972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
    Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
    Front Immunol; 2019; 10():1624. PubMed ID: 31379829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
    Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
    Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.